查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387345

靜脈注射(IV Solutions) 市場報告：2030 年趨勢、預測與競爭分析

Intravenous Solution Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

靜脈注射（IV 溶液）的趨勢和預測

預計到 2030 年，全球靜脈注射市場將達到 233 億美元，2024 年至 2030 年複合年成長率為 8.1%。這個市場的主要促進因素是胃腸道疾病、神經系統疾病和癌症等疾病盛行率的上升，診所、醫院和專科護理單位等醫療設施的快速成長以及先進醫療技術的發展。全球靜脈注射市場前景廣闊，全腸外營養及週邊腸外營養市場充滿機會。

靜脈注射輸液市場洞察

Lucintel 預測，在預測期內，單給藥胺基酸將繼續成為最大的區隔市場，因為它們為無法透過正常消化方式用餐或吸收足夠的患者提供完整的營養支持。

由於主要企業較多、藥品容易取得以及完善的醫療保健基礎設施，預計歐洲在預測期內將出現最高的成長。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球靜脈注射市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球靜脈注射注射市場趨勢（2018-2023）與預測（2024-2030）
  • 依產品分類的全球靜脈注射市場
    • 完全腸外營養
    • 週邊腸外營養
  • 依營養素分類的全球靜脈注射市場
    • 碳水化合物
    • 維生素和礦物質
    • 單給藥胺基酸
    • 腸外脂肪乳劑
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球靜脈注射市場區域分佈
  • 北美靜脈注射市場
  • 歐洲靜脈注射市場
  • 亞太靜脈注射市場
  • 其他地區靜脈注射市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依產品分類的全球靜脈注射市場成長機會
    • 全球靜脈注射市場營養素的成長機會
    • 依地區分類的全球靜脈注射市場成長機會
  • 全球靜脈注射市場新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球靜脈注射市場產能
    • 全球靜脈注射輸液市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Pfizer
  • Otsuka Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Vifor Pharma Management
  • Grifols
  • Henry Schein
  • Soxa Formulations & Research
  • B. Braun Melsungen
  • Baxter International
  • Fresenius Kabi
簡介目錄

Intravenous Solution Trends and Forecast

The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets. The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.

A more than 150-page report is developed to help in your business decisions.

Intravenous Solution by Segment

The study includes a forecast for the global intravenous solution by product, nutrients, and region.

Intravenous Solution Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Total Parenteral Nutrition
  • Peripheral Parenteral Nutrition

Intravenous Solution Market by Nutrients [Shipment Analysis by Value from 2018 to 2030]:

  • Carbohydrates
  • Vitamins & Minerals
  • Single Dose Amino Acids
  • Parenteral Lipid Emulsion
  • Others

Intravenous Solution Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Intravenous Solution Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intravenous solution companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intravenous solution companies profiled in this report include-

  • Pfizer
  • Otsuka Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Vifor Pharma Management
  • Grifols
  • Henry Schein
  • Soxa Formulations & Research
  • B. Braun Melsungen
  • Baxter International
  • Fresenius Kabi

Intravenous Solution Market Insights

Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.

Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.

Features of the Global Intravenous Solution Market

Market Size Estimates: Intravenous solution market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Intravenous solution market size by product, nutrients, and region in terms of value ($B).

Regional Analysis: Intravenous solution market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, nutrients, and regions for the intravenous solution market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intravenous solution market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the intravenous solution market size?

Answer: The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030.

Q2. What is the growth forecast for intravenous solution market?

Answer: The global intravenous solution market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the intravenous solution market?

Answer: The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.

Q4. What are the major segments for intravenous solution market?

Answer: The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets.

Q5. Who are the key intravenous solution market companies?

Answer: Some of the key intravenous solution companies are as follows:

  • Pfizer
  • Otsuka Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Vifor Pharma Management
  • Grifols
  • Henry Schein
  • Soxa Formulations & Research
  • B. Braun Melsungen
  • Baxter International
  • Fresenius Kabi

Q6. Which intravenous solution market segment will be the largest in future?

Answer: Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.

Q7. In intravenous solution market, which region is expected to be the largest in next 5 years?

Answer: Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the intravenous solution market by product (total parenteral nutrition and peripheral parenteral nutrition), nutrients (carbohydrates, vitamins & minerals, single dose amino acids, parenteral lipid emulsion, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Intravenous Solution Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Intravenous Solution Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Intravenous Solution Market by Product
    • 3.3.1: Total Parenteral Nutrition
    • 3.3.2: Peripheral Parenteral Nutrition
  • 3.4: Global Intravenous Solution Market by Nutrients
    • 3.4.1: Carbohydrates
    • 3.4.2: Vitamins & Minerals
    • 3.4.3: Single Dose Amino Acids
    • 3.4.4: Parenteral Lipid Emulsion
    • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Intravenous Solution Market by Region
  • 4.2: North American Intravenous Solution Market
    • 4.2.2: North American Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
  • 4.3: European Intravenous Solution Market
    • 4.3.1: European Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
    • 4.3.2: European Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
  • 4.4: APAC Intravenous Solution Market
    • 4.4.1: APAC Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
    • 4.4.2: APAC Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
  • 4.5: ROW Intravenous Solution Market
    • 4.5.1: ROW Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
    • 4.5.2: ROW Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Intravenous Solution Market by Product
    • 6.1.2: Growth Opportunities for the Global Intravenous Solution Market by Nutrients
    • 6.1.3: Growth Opportunities for the Global Intravenous Solution Market by Region
  • 6.2: Emerging Trends in the Global Intravenous Solution Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Intravenous Solution Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intravenous Solution Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Pfizer
  • 7.2: Otsuka Pharmaceutical
  • 7.3: Sichuan Kelun Pharmaceutical
  • 7.4: Vifor Pharma Management
  • 7.5: Grifols
  • 7.6: Henry Schein
  • 7.7: Soxa Formulations & Research
  • 7.8: B. Braun Melsungen
  • 7.9: Baxter International
  • 7.10: Fresenius Kabi